Health Care & Life Sciences » Pharmaceuticals | Il-Yang Pharmaceutical Co. Ltd.

Il-Yang Pharmaceutical Co. Ltd. | Ownership

Companies that own Il-Yang Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
National Pension Service of Korea
1,349,099
7.08%
192,813
0.03%
05/11/2018
The Vanguard Group, Inc.
296,390
1.56%
56
0%
07/31/2018
Mirae Asset Global Investments Co., Ltd.
244,083
1.28%
-24,694
0.06%
04/30/2018
BlackRock Fund Advisors
191,632
1.01%
0
0%
09/05/2018
Norges Bank Investment Management
159,235
0.84%
108,704
0%
12/31/2017
Dimensional Fund Advisors LP
89,507
0.47%
39,883
0%
04/30/2018
BlackRock Advisors (UK) Ltd.
29,758
0.16%
0
0%
09/05/2018
Charles Schwab Investment Management, Inc.
15,839
0.08%
0
0%
09/06/2018
SSgA Funds Management, Inc.
8,684
0.05%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
7,945
0.04%
0
0%
03/31/2018

About Il-Yang Pharmaceutical Co.

View Profile
Address
110 Hagal-ro
Yongin GY 17096
Korea, Republic Of
Employees -
Website http://www.ilyang.co.kr
Updated 07/08/2019
Il-Yang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products are medicines including ethical and over-the counter drugs under the brand names of NolTec, Supect, and Wonbi-D. The company was founded on July 1, 1946 and is headquartered in Yongin, South Korea.